DOD Melanoma Research Program (Focused Program/Team Science/Idea Awards) – Application

Well-being, Health and Biomedical Discovery

Deadlines

Academic Unit: Inquire with unit

Memorial Deadline: Thursday 8th, October 2026

External Deadline: Wednesday 14th, October 2026


Description

The Melanoma Research Program (MRP) released program announcements for the following funding opportunities:

  • Focused Program Award – Rare Melanomas
    The FY26 MRP FPA-RM supports a multidisciplinary research program of at least two, but not
    more than three, distinct but complementary projects addressing an overarching question
    relevant to rare melanomas (see Figure 1). Applications for the FPA-RM may propose
    projects across the entire research spectrum (biology, etiology, prevention, diagnosis
    and detection, prognosis, treatment and quality of life) and must address a critical unmet
    need relevant to rare melanomas.
  • Idea Award
  • The FY26 MRP Idea Award supports innovative, untested, exploratory, high-risk/potentially highreward concepts, theories, paradigms or methods that address at least one of the FY26 MRP
    Focus Areas. The intent of the Idea Award is to generate new research avenues for investigation;
    therefore, novelty and innovation should be key aspects of the proposed project.
    Research supported by the Idea Award must introduce a new paradigm, challenge existing
    paradigms, look at existing problems from new perspectives or exhibit other highly creative
    qualities.
  • Team Science Award
    The intent of the FY26 MRP Team Science Award (TSA) is to support a broad range of
    hypothesis-driven, multidisciplinary studies that are responsive to at least one of the FY26 MRP
    Focus Areas and have the short-term goal of advancing the state of the science in melanoma
    research and/or patient care. Team science is a synergistic effort that harnesses techniques,
    approaches, and perspectives from multiple disciplines and/or therapeutic areas to address
    complex, multi-dimensional problems that will impact patient outcomes. The TSA is intended to
    bring together investigators from divergent disciplines to achieve innovations and advancements in melanoma research and/or patient care that could not be achieved by any one investigator working independently. While basic research is allowed, all applications are expected to articulate the short- and long-term benefits of the expected research outcomes for the melanoma patient community.To view the MRP funding opportunity announcements and submit a pre-application, visit https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=719110

Pre-Application Due: July 13, 2026
Application Due: October 14, 2026


Funding Sources

Department of Defence - United States of America



This opportunity was posted by: RGCS

Last modified: June 1, 2026